Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s40265-016-0647-3 | DOI Listing |
Publication Analysis
Top Keywords
erratum brodalumab
4
brodalumab global
4
global approval
4
erratum
1
global
1
approval
1
Similar Publications
Corrigendum to Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update.
J Psoriasis Psoriatic Arthritis
October 2023
[This corrects the article DOI: 10.1177/2475530320925067.].
View Article and Find Full Text PDFCorrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis.
J Psoriasis Psoriatic Arthritis
October 2023
Article Synopsis
- The article DOI: 10.1177/2475530320970530 has been amended to address inaccuracies or errors found in the original work.
- The corrections made aim to improve the clarity and credibility of the information presented.
- Readers are encouraged to refer to the updated article for the most accurate and reliable content.
Erratum to: Brodalumab: First Global Approval.
Drugs
October 2016
Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!